| Technology for Life |
| @ 2008 Copyright GenxBio-All rights reserved Terms of use |
GenxBio R & D coming soon:
Expansion Attributed to Increased Use in Drug and Vaccine Development
Continued growth and a changing landscape characterize the custom peptides marketplace, as suppliersramp up capacity to meet rising demand in both the research and therapeutics markets. With pharma
increasingly focusing on biologics and moving peptide drugs through their pipelines into late-stage
development, and the research community focusing significant resources on vaccines and biomarker
discovery, the demand for higher quality proteins and peptides, large peptide libraries for screening
applications, and modified GMP peptides with improved stability profiles and pharmacokinetic properties
is driving double-digit annual growth.
Even as strong demand shows no signs of abating, at least in the near term, building pressures to drive
down costs, assure higher quality-control standards, and increase the throughput and efficiency of
synthesis processes will continue to drive development of novel synthesis, modification, and purification
strategies, encourage companies to target emerging markets, and expand globally to maintain a
competitive advantage.
Trends to watch include rapid growth in the areas of vaccines, biomarkers, and protein therapeutics, the
growing popularity of microwave-based peptide synthesis technology, and innovative strategies to
enhance delivery and bioavailability of peptide drugs, as well as increasing investment in Asia especially
China and India and the emergence of Chinese & Indian companies competing for global market share for
custom peptides and raw materials. To cope up the demands raised by scientific community, GenxBio
decided to start peptide synthesis service in India. This will help us fulfilling our countries and foreign
countiry requirement.
 | Introducing Peptide synthesis services in India very soon |
Expansion Attributed to Increased Use in Drug and Vaccine Development
Continued growth and a changing landscape characterize the custom peptides marketplace, as suppliers
increasingly focusing on biologics and moving peptide drugs through their pipelines into late-stage
development, and the research community focusing significant resources on vaccines and biomarker
discovery, the demand for higher quality proteins and peptides, large peptide libraries for screening
applications, and modified GMP peptides with improved stability profiles and pharmacokinetic properties
is driving double-digit annual growth.
Even as strong demand shows no signs of abating, at least in the near term, building pressures to drive
down costs, assure higher quality-control standards, and increase the throughput and efficiency of
synthesis processes will continue to drive development of novel synthesis, modification, and purification
strategies, encourage companies to target emerging markets, and expand globally to maintain a
competitive advantage.
Trends to watch include rapid growth in the areas of vaccines, biomarkers, and protein therapeutics, the
growing popularity of microwave-based peptide synthesis technology, and innovative strategies to
enhance delivery and bioavailability of peptide drugs, as well as increasing investment in Asia especially
China and India and the emergence of Chinese & Indian companies competing for global market share for
custom peptides and raw materials. To cope up the demands raised by scientific community, GenxBio
decided to start peptide synthesis service in India. This will help us fulfilling our countries and foreign
countiry requirement.
| ||||||||||||||||
 | |  | |  | |  | |  | |  | |  | |  |
|
|
|
|